Radiation induced Activation of Anti-tumor Immunity for Head and Neck Cancer

Radiation induced Activation of Anti-tumor Immunity for Head and Neck Cancer - Radiation induced Immunity for H&N Cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032363

Enrollment

100

Registered

2018-05-01

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients giving written informed consent to participate this study 2.Male or female patients aged 20 years or older at the time of diagnosis of head and neck cancers, who are planned for taking radiation therapy or chemo-radiation therapy.

Exclusion criteria

Exclusion criteria: 1.Patients who are regarded as inappropriate to participate in the study by the primary investigators 2.Patients with serious liver dysfunction or renal dysfunction 3.Pregnant or lactating females 4.Patients with clinically significant psychiatric disease that would interfere with participation in this study

Design outcomes

Primary

Measure	Time frame
1. To estimate immune-related factors by measurement substances in blood and histopathological examination for cancer tissues 2. To estimate treatment response and prognosis 3. To summarize treatment outcomes stratified by immune-related factors and clinical characteristics	—

Countries

Japan

Contacts

Public ContactTakashi Toshiyasu

The Cancer Institute Hospital of Japanese Foundation for Cancer Research (JRCR) Radiation Oncology Department

takashi.toshiyasu@jfcr.or.jp03-3520-0111

Outcome results